Discovery and functional characterization of small molecule inhibitors of SWI/SNFATPase activity in BRG1/SMARCA4-Deficient non small cell lung cancers

被引：0
|
作者：
Jagani, Z. [1 ]
Chenail, G. [1 ]
Xiang, K. [1 ]
Bushold, G. [1 ]
Bhang, C. [1 ]
Li, A. [1 ]
Vattay, A. [1 ]
Gilbert, T. [1 ]
Zhu, J. [2 ]
Terranova, R. [3 ]
Dubost, V. [3 ]
Huet, F. [4 ]
Farley, D. [5 ]
Cantwell, J. [6 ]
Ruddy, D. [1 ]
Rakiec, D. [1 ]
Shirley, M. [1 ]
Elliott, G. [1 ]
Nakajima, K. [7 ]
Papillon, J. [7 ]
机构：
[1] Novartis Inst BioMed Res, Oncol, Cambridge, MA USA
[2] Novartis Inst BioMed Res, Sci Data Analyt, Cambridge, MA USA
[3] Novartis Inst BioMed Res, Preclin Safety, Basel, Switzerland
[4] Novartis Inst BioMed Res, PreClin Safety, Cambridge, MA USA
[5] Novartis Inst BioMed Res, Chem Biol & Therapeut, Cambridge, MA USA
[6] Novartis Inst BioMed Res, Prot Sci, Emeryville, CA USA
[7] Novartis Inst BioMed Res, Global Discovery Chem, Cambridge, MA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19 (PB-199
引用
收藏
页码：E23 / E23
页数：1
相关论文
共 50 条
  • [21] Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies
    Ng, Jin
    Cai, Ling
    Girard, Luc
    Prall, Owen W. J.
    Rajan, Neeha
    Khoo, Christine
    Batrouney, Ahida
    Byrne, David J.
    Boyd, Danielle K.
    Kersbergen, Ariena J.
    Christie, Michael
    Minna, John D.
    Burr, Marian L.
    Sutherland, Kate D.
    CLINICAL CANCER RESEARCH, 2024, 30 (09) : 1846 - 1858
  • [22] Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers
    Papillon, Julien P. N.
    Nakajima, Katsumasa
    Adair, Christopher D.
    Hempel, Jonathan
    Jouk, Andriana O.
    Karki, Rajeshri G.
    Mathieu, Simon
    Mobitz, Henrik
    Ntaganda, Rukundo
    Smith, Troy
    Visser, Michael
    Hill, Susan E.
    Hurtado, Felipe Kellermann
    Chenail, Gregg
    Bhang, Hyo-Eun C.
    Bric, Anka
    Xiang, Kay
    Bushold, Geoffrey
    Gilbert, Tamara
    Vattay, Anthony
    Dooley, Julie
    Costa, Emily A.
    Park, Isabel
    Li, Ailing
    Farley, David
    Lounkine, Eugen
    Yue, Q. Kimberley
    Xie, Xiaoling
    Zhu, Xiaoping
    Kulathila, Raviraj
    King, Daniel
    Hu, Tiancen
    Vulic, Katarina
    Cantwell, John
    Luu, Catherine
    Jagani, Zainab
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (22) : 10155 - 10172
  • [23] Inactivation of BRG1 in non-small cell lung cancer (NSCLC) cell lines
    Zhang, Wei
    Valencia, Ilse
    Yan, Jingsheng
    Chari, Raj
    Girard, Luc
    Soh, Junichi
    Tam, Kit
    Xie, Yang
    Lam, Wan
    Minna, John
    Gazdar, Adi
    CANCER RESEARCH, 2010, 70
  • [24] Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab
    Lin, Yun-Tzu
    Li, Chien-Feng
    Wu, Hung-Chang
    Jan, Yi-Hua
    Kuo, Yu-Hsuan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [25] A Case of SMARCA4-Deficient Non-Small Cell Lung Carcinoma with Aggressive Clinical Course and Poor Response to Chemotherapy
    Khan, N.
    Jani, P.
    Zhao, B.
    Jafri, S.
    Zhang, S.
    Sun, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [26] Fine-needle aspiration and effusion cytology of thoracic SMARCA4-deficient undifferentiated tumor and SMARCA4-deficient non-small cell lung carcinoma: A multi-institutional experience with 27 patients
    Zalles, Nicole
    Mukhopadhyay, Sanjay
    Satturwar, Swati
    Lajara, Sigfred
    Khader, Samer
    Pantanowitz, Liron
    Elsheikh, Tarik M.
    CANCER CYTOPATHOLOGY, 2025, 133 (01)
  • [27] Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type
    Karnezis, Anthony N.
    Wang, Yemin
    Ramos, Pilar
    Hendricks, William P. D.
    Oliva, Esther
    D'Angelo, Emanuela
    Prat, Jaime
    Nucci, Marisa R.
    Nielsen, Torsten O.
    Chow, Christine
    Leung, Samuel
    Kommoss, Friedrich
    Kommoss, Stefan
    Silva, Annacarolina
    Ronnett, Brigitte M.
    Rabban, Joseph T.
    Bowtell, David D.
    Weissman, Bernard E.
    Trent, Jeffrey M.
    Gilks, C. Blake
    Huntsman, David G.
    JOURNAL OF PATHOLOGY, 2016, 238 (03): : 389 - 400
  • [28] Expanding the Immunophenotype Spectrum of SMARCA4-Deficient Non-Small Cell Lung Carcinomas: A Case Series with Neuroendocrine Markers Expression
    Mao, Ruiqi
    Liu, Min
    Shu, Xiangfang
    Li, Wenli
    Yan, Wei
    Li, Xinjun
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2022, 30 (03) : 251 - 259
  • [29] SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer
    Bell, Erica Hlavin
    Chakraborty, Arup R.
    Mo, Xiaokui
    Liu, Ziyan
    Shilo, Konstantin
    Kirste, Simon
    Stegmaier, Petra
    McNulty, Maureen
    Karachaliou, Niki
    Rosell, Rafael
    Bepler, Gerold
    Carbone, David P.
    Chakravarti, Arnab
    CLINICAL CANCER RESEARCH, 2016, 22 (10) : 2396 - 2404
  • [30] Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcemic type.
    Karnezis, Anthony N.
    Wang, Yemin
    Ramos, Pilar
    Hendricks, William
    Yin, Holly
    Oliva, Esther
    D'Angelo, Emanuela
    Prat, Jaime
    Nucci, Marisa R.
    Nielsen, Torsten O.
    Weissman, Bernard E.
    Trent, Jeffrey M.
    Gilks, C. Blake
    Huntsman, David G.
    CLINICAL CANCER RESEARCH, 2016, 22
12345